Search

Your search keyword '"Pieter De Visschere"' showing total 99 results

Search Constraints

Start Over You searched for: Author "Pieter De Visschere" Remove constraint Author: "Pieter De Visschere"
99 results on '"Pieter De Visschere"'

Search Results

1. Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancer

2. Exclusion of non-Involved uterus from the target volume (EXIT-trial): An individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques followed by completion surgery

Catalog

Books, media, physical & digital resources

4. Clinical Application of the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Score for Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer

5. Is It Safe to Switch from a Standard Anterior to Retzius-Sparing Approach in Robot-Assisted Radical Prostatectomy?

6. Breast Amyloidosis: A Case Report and Literature Review

7. Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial

8. Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients

9. Cervical Adenoma Malignum in Third Trimester Pregnancy

10. B-Cell Acute Lymphoblastic Leukaemia of the Uterus

11. Bladder Paraganglioma

12. Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates

13. EXclusion of non-Involved uterus from the Target Volume (EXIT-trial): an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques

14. A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response

15. Renal Arteriovenous Fistula

18. MRI of Paratubal Borderline Serous Tumor

19. Multidisciplinary approach to prostatitis

21. Reverse Rim Sign

24. Role of Imaging in the Diagnosis and Management of Complete Androgen Insensitivity Syndrome in Adults

26. Safety of pre- or postoperative accelerated radiotherapy in 5 fractions: A randomized pilot trial

28. Primary renal sarcomas: imaging features and discrimination from non-sarcoma renal tumors

29. Alport syndrome with pelvic leiomyomatosis : the role of hormonal suppression

30. Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial

31. V04-07 3D SELECTIVE ARTERIAL CLAMPING IN ROBOT ASSISTED PARTIAL NEPHRECTOMY

32. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort

33. Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center

34. Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma

35. Aggressive variants of prostate cancer – Are we ready to apply specific treatment right now?

36. Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review

37. Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer

38. Imaging in scrotal trauma: a European Society of Urogenital Radiology Scrotal and Penile Imaging Working Group (ESUR-SPIWG) position statement

39. How does PI-RADS v2.1 impact patient classification? A head-to-head comparison between PI-RADS v2.0 and v2.1

40. MP79-01 EXTERNAL VALIDATION OF THE 2019 BRIGANTI NOMOGRAM FOR THE IDENTIFICATION OF PROSTATE CANCER PATIENTS WHO SHOULD BE CONSIDERED FOR AN EXTENDED PELVIC LYMPH NODE DISSECTION

41. A case report and a literature review of primary retroperitoneal mucinous cystadenoma: the importance of imaging in diagnosis and management

42. Renal Arteriovenous Fistula

43. Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250](S0302283819307638)(10.1016/j.eururo.2019.09.035)

44. External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection

45. Multiparametric MRI of the Prostate: From Scientific Triumph to Daily Practice

46. Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients

47. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort

48. T-staging of prostate cancer: Identification of useful signs to standardize detection of posterolateral extraprostatic extension on prostate MRI

49. Retrospective analysis of multiparametric MRI to predict complete pathologic response after neo-adjuvant chemotherapy for muscle invasive bladder cancer

50. Whole pelvis radiotherapy for pathological node-positive prostate cancer